Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)

Immunology
0
Pipeline Programs
5
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
German Spondyloarthritis Inception CohortN/A
Novartis
NovartisBASEL, Switzerland
1 program
German Spondyloarthritis Inception CohortN/A
Amgen
AmgenTHOUSAND OAKS, CA
1 program
German Spondyloarthritis Inception CohortN/A1 trial
Active Trials
NCT01277419Recruiting1,000Est. Jul 2030
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
German Spondyloarthritis Inception CohortN/A
UP
UCB PharmaBelgium - Brussels
1 program
German Spondyloarthritis Inception CohortN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
AmgenGerman Spondyloarthritis Inception Cohort

Clinical Trials (1)

Total enrollment: 1,000 patients across 1 trials

NCT01277419AmgenGerman Spondyloarthritis Inception Cohort

German Spondyloarthritis Inception Cohort

Start: Jul 2000Est. completion: Jul 20301,000 patients
N/ARecruiting

Related Jobs in Immunology

Regulatory Affairs Manager(Immunology), Korea

AbbVie
Seoul, Seoul
10h ago

Regional Sales Trainer - Rheumatology (Mid Atlantic/Central)

AbbVie
Remote
11h ago

Field Reimbursement Manager - Rheumatology - Seattle, WA (North)

Johnson & Johnson
Seattle, Washington, United States of America
Yesterday
$100K - $175K/yr

Senior Medical Science Liaison, Dermatology - Indianapolis

Johnson & Johnson
Indianapolis, Indiana, United States
Yesterday
$137K - $236K/yr

Senior Area Business Specialist, Immunology - Detroit, MI - Johnson & Johnson Innovative Medicine

Johnson & Johnson
Detroit, Michigan, United States
Yesterday

Senior Clinical Trial Physician, Rheumatology

Bristol Myers Squibb
Princeton - NJ - US
Yesterday
$309K - $374K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,000 patients
5 companies competing in this space

Related Indications

Rheumatoid Arthritis(475)Psoriasis(206)Ulcerative Colitis(151)Atopic Dermatitis(144)Crohn's Disease(140)Systemic Lupus Erythematosus(85)Arthritis, Rheumatoid(61)Plaque Psoriasis(53)Crohn Disease(49)Ankylosing Spondylitis(33)